3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: March 4, 2020
Period of Report: March 2, 2020
Accession Number: 0001735276-20-000037

View Document ↗ View on SEC.gov ↗